Table 1 Patients characteristics.
From: Diagnosis and clinical significance of prostate calcification using computed tomography
Variable | No calcification | Calcification < HU100 | Calcification ≥ HU100 | p-value |
|---|---|---|---|---|
No. | 1,525 | 285 | 2,995 | |
Mean age ± SD, year | 52.3 ± 15.9 | 57.8 ± 13.9 | 60.5 ± 13.6 | < 0.001 |
Current use of urologic medication, n (%)a | 102 (6.7) | 18 (6.3) | 213 (7.1) | 0.355 |
Diabetes, n (%) | 362 (23.7) | 67 (23.5) | 763 (25.4) | 0.663 |
Hypertension, n (%) | 178 (11.7) | 34 (11.9) | 380 (12.7) | 0.326 |
Mean body mass index ± SD, kg/m2 | 24.1 ± 2.8 | 23.6 ± 2.8 | 23.9 ± 2.9 | 0.449 |
Mean PSA ± SD, ng/ml | 1.68 ± 1.7 | 1.63 ± 1.8 | 1.81 ± 2.0 | 0.109 |
Mean Prostate volume on TRUS ± SD, ml | 24.4 ± 6.9 | 24.3 ± 7.1 | 25.3 ± 6.8 | 0.112 |
Mean serum uric acid level ± SD, mg/dl | 5.8 ± 1.5 | 5.4 ± 1.4 | 5.7 ± 1.5 | 0.067 |
Mean total cholesterol ± SD, mg/dl | 172.6 ± 38.1 | 171.3 ± 36.9 | 169.7 ± 34.6 | 0.078 |
Mean IPSS total ± SD | 11.7 ± 8.6 | 13.0 ± 10.0 | 13.9 ± 9.2 | < 0.001 |
Mean IPSS storage ± SD | 5.0 ± 4.5 | 5.6 ± 5.2 | 5.8 ± 4.8 | 0.013 |
Mean IPSS voiding ± SD | 6.7 ± 4.9 | 7.5 ± 5.6 | 8.0 ± 5.3 | < 0.001 |
Mean IPSS Quality of life ± SD | 2.6 ± 1.7 | 2.9 ± 1.7 | 3.0 ± 1.7 | 0.001 |
